Trisalus Life Sciences Inc (TLSI) Annual Balance Sheets

Annual · GAAP · USD millions
Access TLSI quarterly Balance Sheets →
Tracking balance sheet results across Trisalus Life Sciences Inc to Dec 31 2021 helps illustrate how Dec 31 2025's financial position has responded to changing business conditions.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent20.44
Cash & Short-term Investments20.00
Accounts receivable6.56
Inventories3.08
Prepaid Expense, Current AS2.17
Total Current Assets32.24
Intangible Assets0.00
Other Assets, Noncurrent3.09
Operating Lease Right Of Use Asset0.86
Total Assets35.33
Liabilities
Accounts Payable, Trade, Current3.00
Accrued Liabilities, Current AC8.10
Other Liabilities, Current0.40
Taxes Payable0.00
Total Current Liabilities11.50
Long-term debt33.05
Total Long-term Debt33.05
Derivative Liability, Noncurrent DE12.89
Other liabilities, Noncurrent11.76
LeaseLiabilityNoncurrent1.23
Lease Liability Current0.17
Total Liabilities69.19
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock296.72
Retained Earnings / Accumulated Deficit-330.58
Other Equity0.00
Common Stockholder's Equity-33.86
Non-controlling interests & other0.00
Total Stockholder's Equity-33.86
Liabilities & Stockholder's Equity35.33
4 historic quarters locked

Sign in to unlock the full Trisalus Life Sciences Inc balance sheet history.

About Trisalus Life Sciences Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-015163

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.